Home News Insights Trading halts Paper trading Guide Community My account

Market calendarNext market opening

Display in USD

Loading news article.

U.S. stock guide
Scanner guide
Paper trading guide
Terms of service
Privacy policy
Announcements
FAQ

Support: help@wapeb.comPartnerships: partnership@wapeb.com

WAPE is a free research, analysis and paper trading service. It does not place real securities orders. Market data and AI summaries are for information only, not investment advice or stock recommendations. Information may include delays, errors or estimates. Check original sources and supporting materials. You are responsible for your investment decisions and any resulting gains or losses.

Language한국어 English

Copyright © WAPE. All rights reserved.

Loading news article.

Guggenheim Initiates Kazia Therapeutics at Buy With $35 Price Target | WAPE

Newsfiscal.ai

Guggenheim Initiates Kazia Therapeutics at Buy With $35 Price Target

Oct 21, 2026, 18:02 ET · Published

Article summary

Guggenheim has initiated coverage on Kazia Therapeutics with a 'Buy' rating and a price target of $35.00 per share.

An excerpt from the original article.

Related companies

Kazia Therapeutics Limited American Depositary SharesKZIAView stock

Analyzed by WAPE AI.

Preparing English content…

Comments —

Comment

Loading comments…